 |
Brent DuBeshter, M.D.
Dr. DuBeshter is currently Associate Professor of Oncology in the Department
of Ob/Gyn and Director of the Division of Gynecologic Oncology. Dr.
DuBeshter received his undergraduate degree from Franklin and Marshall
College and his MD degree from the University of Virginia. He completed
a residency in Obstetrics and Gynecology as well as a Fellowship in
Gynecologic Oncology at the Brigham and Women's Hospital of Harvard
Medical School. He is Board certified in Ob/Gyn and Gyn Oncology.
Current areas of interest:
- Gynecologic Cancers - Ovarian Cancer Treatment, Endometrial Cancer, Cervical Cancer
- Gestational Trophoblastic Disease
How to contact Dr. DuBeshter:
E-Mail Address: Brent_DuBeshter@urmc.rochester.edu
Phone: (585) 442-8020
Link to: Strong Health
Current research and publications:
- Reynolds EA, DuBeshter B, Katzman P, Larson K, Katzel S, and Glantz C.
Expression of CD44, E-cadherin and anit-metastatic nm23H1 in complete hydatidiform moles. Gynecol Oncol 2006 (in press)
- DuBeshter B, Estler K, Altobelli K, McDonald
S, Glantz C, and Angel C, High-dose rate brachytherapy for Stage
I/II papillary serous or clear cell endometrial cancer. Gynecol
Oncol 2004;94:383-386
- Thigpen JT, Brady MF, Homesley HD, Malfetano J, DuBeshter
B, Burger RA, Liao S,. Phase III trial of doxorubicin with
or without cisplatin in advanced endometrial carcinoma: a gynecologic
oncology group study. J Clin Oncol 2004;22(19):3902-8
- DuBeshter B, Estler K, Altobelli K, McDonald S, Glantz
C, and Angel C, High-dose rate brachytherapy for Stage I/II papillary
serous or clear cell endometrial cancer. Gynecol Oncol (in
press) .
- DuBeshter B, Deuel C, Gillis S, Glantz C, Angel C, Guzick
D, Endometrial Cancer: The Potential Role of Cervical Cytology in
Current Surgical Staging. Obstet Gynecol 2003; 101:445-50.
- Arkoulakis NS, Angel CL, DuBeshter B, Serletti JM, Reconstruction
of an extensive vulvectomy defect using the gluteus maximus fasciocutaneous
v-y advancement flap. Ann Plast Surg 2002;49:50-4.
- DuBeshter B, Endometrial cancer: predictive value of cervical
cytology. Gynecol Oncol 1999;72:271-2.
- Morrow GR, Hickok JT, DuBeshter B, Lipshultz SE, Changes
in clinical measures of autonomic nervous system function related
to cancer chemotherapy-induced nausea. J Auton Nerv Sys 1999;78:57-63.
Book chapters:
- DuBeshter B, “Gynecology” in Schwartz, Shires, Spencer
(ed.), Principles of Surgery, 7th ed., Companion Handbook,
McGraw Hill, Gynecology
- DuBeshter B, "Gynecologic Cancers" in Leppert P (ed.), Primary Care for Women, Philadelphia, PA: Lippincott-Raven, 2003.
Presentations:
- DuBeshter B, Estler K, Altobelli K, and Angel
C. High-dose rate brachytherapy for Stage I/II papillary serous
or clear cell endometrial cancer. Int J Gynecol Cancer 2004:14(supp);91
- Brown AK, Gillis S, Deuel C, Angel C, Glantz C, and DuBeshter
B, Abnormal Cervical Cytology: A Risk Factor for Recurrence
of Endometrial Cancer. Int J Gynecol Cancer 2004:14(supp);133
- DuBeshter B, Walsh C, Altobelli K, and Angel
C. Automation of chemotherapy dosing: improved efficiency and elimination
of dosing errors. Int J Gynecol Cancer 2004:14(supp);135
Awards and Honors :
-
CREOG National Faculty Award for Teaching Excellence
Maintained by Medicine
Web Services
Updated August 11, 2006
|
